Atlas Trials

Safety and Pharmacokinetics of Linzagolix in Female Subjects With Normal and Impaired Renal Function

Clinical trial NCT03961932 · COMPLETED

Trial details

NCT number
NCT03961932
Sponsor
ObsEva SA
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Renal ImpairmentHealthy Participants
Start date
2019-05-15
Primary completion
2020-01-22
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.